Idun Biologics ApS: Financial statements 2025
CVR: 43750380
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
Idun Biologics ApS (CVR 43750380) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 475,329 and a net result of DKK -85,011 compared with DKK -192,043 the year before. That is a decrease of 8% compared with the year before. Equity in the 2025 report amounted to DKK -239,341. The company had 1 employee in the financial year.
- Gross Profit
- DKK 475,329
- Profit/Loss
- DKK -85,011
- Equity
- DKK -239,341
- Total Assets
- DKK 1,255,753
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | 475K | -85K | -239K | 1 |
| 2024 | - | 517K | -192K | -154K | 2 |
| 2023 | - | 662K | -2K | 38K | 0 |
Official annual report
How creditworthy is Idun Biologics ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
Idun Biologics ApS has published its annual report for 2024. Gross profit came to DKK 516,626, and the net result was DKK -192,043.
About Idun Biologics ApS
Idun Biologics ApS is a Danish company of the type Anpartsselskab based in Aalborg, founded in 2023. The company is registered under the industry Fremstilling af farmaceutiske præparater. The management consists of Clarisse Eve Chiche-Lapierre and Jens Frederik Teilfeldt Hansen. The company is owned by Ymir Holdings ApS. The company has 2 employees (2026). In 2025, the company reported a gross profit of DKK 475,329 and a net result of DKK -85,011 compared with DKK -192,043 the year before. Equity in the 2025 report amounted to DKK -239,341.
